Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:TLX 11 December 2025 - 17 December 2025

Telix Pharmaceuticals (TLX) Stock Slides on Dec. 17, 2025: ProstACT Phase 3 Update, FDA Zircaix Overhang, Lawsuit Headlines, and Fresh Analyst Forecasts

Telix Pharmaceuticals (TLX) Stock Slides on Dec. 17, 2025: ProstACT Phase 3 Update, FDA Zircaix Overhang, Lawsuit Headlines, and Fresh Analyst Forecasts

Telix Pharmaceuticals shares fell 6.61% to A$11.73 on the ASX December 17, with volume at 6.36 million and a 52-week low of A$11.535. Nasdaq-listed shares dropped 6–7% in early U.S. trading. The company issued a statement confirming completion of Part 1 enrollment in its ProstACT Global Phase 3 study after market rumors. TLX591 has not received marketing authorization.
17 December 2025
···
Telix Pharmaceuticals (TLX) Stock: Varian Deal, ProstACT Milestone and Class Actions Redraw the 2025 Outlook

Telix Pharmaceuticals (TLX) Stock: Varian Deal, ProstACT Milestone and Class Actions Redraw the 2025 Outlook

Telix Pharmaceuticals shares fell 6% to US$9.33 in New York on December 11, near a 52-week low, despite trailing 12-month revenue of US$664 million and a new clinical partnership with Varian. The company faces SEC scrutiny, an FDA setback, and multiple class-action lawsuits, but continues to report late-stage oncology progress and expanding collaborations.
11 December 2025
···

Stock Market Today

  • US Stocks, Bonds, and Gold Slide Amid Iran Conflict and Rising Oil Prices
    March 20, 2026, 4:11 PM EDT. US stocks and bonds declined sharply as the Iran war intensified, pushing oil prices up and gold to its worst week in 40 years. The Russell 2000 index fell 2.7%, nearing correction territory (a 10% drop from peak). The Dow dropped 444 points (0.96%), S&P 500 fell 1.51%, Nasdaq slumped 2.01%, with the Nasdaq nearly in correction at down 9.65% since late October. The conflict raised energy prices, elevating inflation concerns and complicating central bank policies. Treasury yields surged, with the 10-year yield reaching 4.39%, the highest since July. Gold plunged 2% on Friday, marking a 10% weekly loss. Brent crude rose 3.26% to $112.19 per barrel. Market uncertainty persists over conflict duration and oil prices, with investors cautious about further downside.
Go toTop